Showing results (11-20 of 566) with videos related to

Sort By:
Pageof 57
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 1999
New drugs in the treatment of Hodgkin's diseaseP Borchmann, R Schnell, V Diehl, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Non-Hodgkin's Lymphoma: A Review of Immunotherapeutic Approaches to TreatmentR Schnell, S Barth, V Diehl, et al.
European Journal of Haematology. Supplementum|August 7, 2001
The role of ifosfamide in the treatment of relapsed and refractory lymphomaM Reiser, H Bredenfeld, A Engert, et al.
Der Internist|January 22, 2004
[Modern pharmacotherapy of Hodgkin disease]A Josting, K Behringer, A Engert, et al.
Medizinische Klinik (Munich, Germany : 1983)|September 14, 2000
["Lean management" in hospitals: potentials and limitations]J P Glossmann, O Schliebusch, V Diehl, et al.
Anticancer Research|January 1, 1987
Intracranial transplantation of human hematopoietic cell lines in nude mice: a preclinical screening model for cytostatic drugsA Engert, H H Kirchner, M Schaadt, et al.
Gene|March 30, 1999
A new series of pET-derived vectors for high efficiency expression of Pseudomonas exotoxin-based fusion proteinsB Matthey, A Engert, A Klimka, et al.
Cytokines, Cellular & Molecular Therapy|October 9, 1999
CD30L-ETA': a new recombinant immunotoxin based on the CD30 ligand for possible use against human lymphomaS Barth, B Matthey, M Huhn, et al.
International Journal of Molecular Medicine|December 16, 1998
Construction and in vitro evaluation of RFT5(scFv)-ETA', a new recombinant single-chain immunotoxin with specific cytotoxicity toward CD25+ Hodgkin-derived cell linesS Barth, M Huhn, W Wels, et al.
Annals of Hematology|October 6, 1998
Rapid tumor lysis in a patient with B-cell chronic lymphocytic leukemia and lymphocytosis treated with an anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab)M Jensen, U Winkler, O Manzke, et al.
Pageof 57